SCHEMBL9007635

SCHEMBL9007635

C=CCC(Cc1ccccc1)C(=O)N(C)C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
MMP14 P50281 1/20 0.47
HPGD P15428 1/20 0.45
CPA3 P15088 3/20 0.44
CPA1 P15085 2/20 0.44
FOLH1 Q04609 1/20 0.44
CPB1 P15086 1/20 0.44
CPB2 Q96IY4 1/20 0.44
LTA4H P09960 1/20 0.43
CYP2C19 P33261 1/20 0.42
MME P08473 3/20 0.42
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
ALOX5 P09917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL252900 0.82 CYP1A2 (0.68) CYP1A2CPA3CPA1FOLH1CPB1
SCHEMBL9007628 0.82 CYP1A2 (0.68) CYP1A2CPA3CPA1FOLH1CPB1
SCHEMBL629350 0.82 CYP1A2 (0.68) CYP1A2CPA3CPA1FOLH1CPB1
SCHEMBL435251 0.79 CYP1A2 (0.50) CYP1A2CYP2C19
SCHEMBL2361534 0.79 CYP1A2 (0.53) CYP1A2HPGDCPA3CPA1FOLH1
SCHEMBL11324047 0.79 CYP1A2 (0.53) CYP1A2CPA3CPA1FOLH1CPB1
SCHEMBL8144720 0.79 CYP1A2 (0.53) CYP1A2CPA3CPA1FOLH1CPB1
SCHEMBL2065619 0.79 CYP1A2 (0.53) CYP1A2CPA3CPA1FOLH1CPB1
SCHEMBL16706484 0.78 CYP1A2 (0.52) CYP1A2MMP9MMP8MMP14HPGD
SCHEMBL28340308 0.76 FAAH (0.47) CYP1A2MMP9MMP8MMP14HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5569762-A Asymmetric synthesis of intermediates for retroviral protease inhibitor compounds AMERICAN CYANAMID COMPANY (US) 1996-10-29 US disclosed
US-5428167-A Asymmetric synthesis of intermediates for retroviral protease inhibitor compounds AMERICAN CYANAMID COMPANY (US) 1995-06-27 US disclosed